Location is the key determinant of use of both effective and risky drug therapies for Medicare Part D beneficiaries, the prescription rates of which vary widely across the nation, according to a new report from the Dartmouth Atlas.
The report examines prescription drug use under Part D of Medicare's drug benefits, separating drugs into proven therapies for heart attack, diabetes or broken bones, discretionary medications and potential harmful medications.
Read eight highlights of the report on Becker's Hospital Review.
More Articles on Quality:
The report examines prescription drug use under Part D of Medicare's drug benefits, separating drugs into proven therapies for heart attack, diabetes or broken bones, discretionary medications and potential harmful medications.
Read eight highlights of the report on Becker's Hospital Review.
